Hjem › Alopesi areata › Indiana
Kliniske studier for Alopesi areata i Indiana
8 studier for Alopesi areata søker deltakere på steder i Indiana.
Byer i Indiana
Offisiell studietekst (engelsk)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dawes Fretzin- Indianapolis /ID# 283498, Indianapolis
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07772492A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- Dawes Fretzin Clinical Research Group, Indianapolis
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Indiana University Health University Hospital /ID# 259827, Indianapolis
RekruttererFase 3
Alder 12 til 63 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RekruttererFase 3
Alder 6 til 14 · Alle kjønn · Oppdatert 28. apr. 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
- Options Research Group, West Lafayette
RekruttererFase 1/2
Alder 18 til 55 · Alle kjønn · Oppdatert 4. mar. 2026 · NCT06826196Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Ds Research - Indiana, Clarksville
- Dawes Fretzin Clinical Research Group Llc., Indianapolis
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 28. jan. 2026 · NCT07133308Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.